The Transcatheter Pulmonary Valve Replacement Market focuses on catheter‑based devices that replace dysfunctional pulmonary valves without the need for open‑heart surgery. Many patients with congenital heart disease—such as repaired tetralogy of Fallot or other right‑ventricular outflow tract reconstructions—develop pulmonary regurgitation or stenosis over time. Traditional...